H-1B sponsorship profile: Vertex Pharmaceuticals Incorporated. Across U.S. Department of Labor LCA disclosures, Vertex Pharmaceuticals Incorporated filed 505 Labor Condition Applications covering 505 H-1B worker positions between fiscal year 2023 and fiscal year 2026. The employer’s DOL certification rate sits at 97.6% (493 certified of 505 filed), a useful proxy for how cleanly their prevailing-wage attestations pass the Labor Department’s preliminary review before USCIS adjudication.

Compensation spread. Offered wages on Vertex Pharmaceuticals Incorporated’s H-1B petitions range from $66,300 at the low end to $305,963 at the high end, with a petition-weighted average of $132,175. That range reflects the mix of occupations the company sponsors, led by Senior Statistical Programmer II (24 petitions at $131,209 avg), followed by Senior Biostatistician II and Principal Statistical Programmer. H-1B salaries reported on LCAs must meet or exceed the DOL prevailing wage for the role and worksite, so the spread also tracks wage-level geography and seniority.

Geographic footprint. Vertex Pharmaceuticals Incorporated is headquartered in Boston, MA under NAICS code 54171, and places H-1B workers across 11 states, most heavily in MA, TX, RI. Combined, these signals give a granular view of how one employer uses the H-1B program, volume, approval cleanliness, wage posture, and where the jobs actually sit on the map.